Ranitidine Hydrochloride recalled over manufacturing violations

Recall date

January 14, 2020

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Spectrum Laboratory Products recalls Ranitidine Hydrochloride (powder), USP, Rx only, Spectrum Chemical Mfg Corp., a) 1 gram, b) 5 grams, c) 25 grams, d)100…

Recall number

D-0825-2020

FDA classification

Class II

Brand / firm

Spectrum Laboratory Products

Sold / distributed

The recalled API was distributed to pharmacies in the following states: AZ, CA, FL, GA, NJ, PA, RI, SC, TX, UT, WY. The API was also distributed internationally to Canada and UAE.

Why it was recalled

CGMP Deviations: Presence of NDMA impurity detected in product.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Ranitidine Hydrochloride (powder), USP, Rx only, Spectrum Chemical Mfg Corp., a) 1 gram, b) 5 grams, c) 25 grams, d)100 grams, e) 500 grams, f) 1 Kilogram